Echocardiography

Cardiac ultrasound uses reflected sound waves (echos) to create images of anatomy inside the body. Echocardiograms are the primary cardiac imaging modality used to assess the heart and diagnose or track cardiac issues. Echo is the gold standard imaging modality to assess the heart, particularly with calculating left ventricular ejection fraction (LVEF), which is a measure of cardiac output. In addition to noninvasive standard transthoracic echo (TTE), invasive transesophgeal echo (TEE) is also used when clearer, more detailed imaging of the heart is needed. Both 3D and 4D echo echo systems are rapidly gaining wider adoption and enable new types of assessments, especially in the structural heart space and in transcatheter procedural guidance. Find news on general ultrasound imaging.

Ultrasight's AI to guide echo cardiac ultrasound POCUS exams at ASE 2023. The thumbnail of the chest shows the user how to the position the transducer and where to move or stop for image acquisition. The bar graph shows the quality of the image.

FDA clears new AI to guide point-of-care cardiac ultrasound exams

The FDA approved UltraSight's AI to show ultrasound users how to perform a diagnostic quality cardiac ultrasound exam at the point of care in multiple settings.

July 31, 2023
Roberto Lang, MD, explained the AI advances in echocardiography that will make it a requirement to have in the coming years at ASE 2023. #ASE #AIhealthcare #ASE2023

Echo labs not using AI will be left behind

Echocardiography expert Roberto Lang, MD, says artificial intelligence will be so important to cardiac ultrasound in the near future that echo labs not using it will be inefficient and less accurate than labs that do use it.

July 3, 2023
An example of HeartFlow's new RoadMap Stenosis software that uses artificial intelligence (AI) to show areas of interest for possible stenting based on a patient's CT scan and FFR-CT. This software is still undergoing beta testing at several hospitals and will likely be rolled out commercially later in 2023.

Cardiology has embraced AI more than most other specialties

Cardiology is linked to the second largest group of FDA-cleared clinical AI algorithms, and the number is still growing. 

May 12, 2023
artificial intelligence AI deep learning

Cardiologists find AI to be more accurate than sonographers at interpreting echocardiograms

Overall, cardiologists made corrections to 16.8% of AI-generated assessments and 27.2% of sonographer assessments.

April 5, 2023
Echocardiography expert Patricia A. Pellikka, MD, discussed the trend of increasing artificial intelligence (AI) integration in cardiac ultrasound with Cardiovascular Business at American College of Cardiology (ACC) 2023 meeting.

AI's growing impact on echocardiography

Cardiology has the second largest number of FDA-cleared AI algorithms, and many of them are for cardiac ultrasound. Echocardiography expert Patricia A. Pellikka, MD, discusses this trend and how AI is helping improve echo.

March 23, 2023
DiA Imaging Analysis, an Israel-based healthcare technology company, has gained U.S. Food and Drug Administration (FDA) clearance for LVivo IQS, a new software solution designed to help users acquire high-quality echocardiography images.

FDA clears new AI-powered cardiac imaging solution

The newly approved software uses artificial intelligence to provide users with real-time feedback related to image quality.

February 6, 2023
As artificial intelligence (AI) adoption expands in radiology, there is growing concern that AI algorithms needs to undergo quality assurance (QA) reviews. How to validate radiology AI? How can you validate medical imaging AI?

Cardiologists use video-based AI model to ID coronary artery disease

A team of specialists out of Cedars-Sinai developed the deep learning model using TTEs from nearly 3,000 patients.

January 26, 2023
Tablet projecting metaphorical medical hologram

AI-powered platform for heart failure detection gains FDA clearance

According to data submitted to the FDA, the platform has been linked to an accuracy of 90%, sensitivity of 87.8% and specificity of 83%.

December 8, 2022

Around the web

The agency is urging healthcare providers to transition away from these devices and seek out alternatives. It is even working with other manufacturers to try and get similar products on the market as quickly as possible. 

Jeffrey Kuvin, MD, one of the leading voices behind efforts to create a new Board of Cardiovascular Medicine, spoke with Cardiovascular Business about where things stand today.

Half a year after President Biden officially directed federal agencies in the executive branch’s bailiwick to “seize the promise and manage the risks” of AI, the White House has posted a status report.

Trimed Popup
Trimed Popup